Catalyst Wire Dossier Catalyst Wire Dossier

Ketoconazole 2% Cream (new formulation)

ketoconazole · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ketoconazole 2% Cream (new formulation), covering 2013-06-06 to 2013-06-06. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy Study of a New Formulation of Ketoconazole 2% Cream in Patients With Tinea Pedis, Commonly Known as Athlete's Foot [Phase 3]

See pricing